Digestive tract polyps and early cancer
Conditions
Interventions
Test group:Disposable endoscope needles produced by Changzhou Heraeus Minimally Invasive Medical Devices Co., Ltd.
Control group:Use disposable needle for injection of endoscopes by Olympus Medical Co., Ltd.
Sponsors
Southern Medical University, Nanfang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-75 years old, male or female; (2) diagnosed as having digestive tract polyps and early cancer by clinical examination Patients with a size <2 cm) who require endoscopic mucosal resection (EMR); (3) The patient agrees to participate in the trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) severe heart, brain, lung and other organ dysfunction, leading to intolerance of endoscopy Healer; (2) Patients with severe blood coagulation disorders; (3) pregnant or lactating women; (4) Patients who have taken anticoagulant drugs within one week; (5) The clinical trial judge judges that the patient is not suitable for the test; (6) Participated in other similar clinical trials within 3 months before the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Injection success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| package;Appearance;Needle surface; | — |
Countries
China
Contacts
Public ContactLiu Side
Nanfang Hospital,Southern Medical University
Outcome results
None listed